Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Po-Ren Hsueh and Nan-Yao Lee.
Po-Ren Hsueh
Connection Strength
1.969
Nan-Yao Lee
  1. Nanoparticles in the Treatment of Infections Caused by Multidrug-Resistant Organisms. Front Pharmacol. 2019; 10:1153.
    View in: PubMed
    Score: 0.845
  2. A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs. Front Pharmacol. 2020; 11:584956.
    View in: PubMed
    Score: 0.228
  3. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic. J Microbiol Immunol Infect. 2020 Jun; 53(3):485-487.
    View in: PubMed
    Score: 0.218
  4. Arguments in favour of remdesivir for treating SARS-CoV-2 infections. Int J Antimicrob Agents. 2020 04; 55(4):105933.
    View in: PubMed
    Score: 0.218
  5. Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART). Infect Drug Resist. 2019; 12:627-640.
    View in: PubMed
    Score: 0.203
  6. Carbapenem-Resistant Enterobacteriaceae Infections: Taiwan Aspects. Front Microbiol. 2018; 9:2888.
    View in: PubMed
    Score: 0.199
  7. Multicenter evaluation of two chemiluminescence and three lateral flow immunoassays for the diagnosis of COVID-19 and assessment of antibody dynamic responses to SARS-CoV-2 in Taiwan. Emerg Microbes Infect. 2020 Dec; 9(1):2157-2168.
    View in: PubMed
    Score: 0.057
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.